| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 05-16-2024 | 03-31-2024 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
RBC Capital analyst Brian Abrahams initiates coverage on Contineum Therapeutics (NASDAQ:CTNM) with a Outperform rating and a...
Stifel analyst Paul Matteis initiates coverage on Contineum Therapeutics (NASDAQ:CTNM) with a Buy rating and announces Price...
Morgan Stanley analyst Jeffrey Hung initiates coverage on Contineum Therapeutics (NASDAQ:CTNM) with a Overweight rating and ...
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...
U.S. stocks were mostly higher, with the Dow Jones index gaining over 100 points on Tuesday.
